Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. IGC Pharma Inc. (IGC) Message Board

420 with CNW — Report from White House Draws Att

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 440
(Total Views: 156)
Posted On: 01/11/2023 4:42:16 PM
Avatar
Posted By: NetworkNewsWire
420 with CNW — Report from White House Draws Attention to Law Enforcement Concerns on Marijuana

Cannabis policing has been an extremely controversial issue in American history. While the war on drugs was ostensibly launched to cripple the criminal organizations behind the illicit drug trade, Black and Brown communities were disproportionately affected by the antidrug campaign. Decades later, the drug war has decimated marginalized communities for minor drug charges and has long been declared an unmitigated failure.

Even though the move to legalize cannabis across the country has been praised by criminal and racial justice activists, the cannabis reform movement hasn’t received everyone’s support. The White House recently issued its annual drug enforcement report to Congress and highlighted several concerns that law enforcement has regarding America’s growing state-level cannabis industry. For instance, the report outlined police concerns about burglaries and robberies in states with legal cannabis markets.

Although cannabis is now legal in more than 30 states, it remains a controlled substance at the federal level. This has largely prevented the state-legal cannabis industry from accessing crucial financial services, such as banking and cashless payment systems, forcing it to operate on a mostly cash-only basis.

Unfortunately, this has made cannabis dispensaries an attractive mark for criminals looking for establishments with plenty of physical cash and movable product on hand. In 2022, an explosion of cannabis dispensary robberies led to increased calls for a cannabis banking bill that would finally grant the industry access to cashless payment services.

The report also stated that despite legalization efforts across the country, the illicit marijuana market is still going strong and supplying a large chunk of the cannabis in America. Some pundits expected that legalization efforts across the country would slow down the illicit market, but the state-legal cannabis industry has largely been unable to compete.

On top of denying states tax revenue from cannabis production and sale, the report added that illicit cannabis growers posed a “serious environmental threat.” The report observed that illegal grows polluted water sources and poisoned wildlife through the unregulated use of pesticides, herbicides and fertilizers.

However, legalization experts have long argued that these reports are biased because they are facilitated through the White House Office of National Drug Control Policy (ONDCP), whose statutory mandate is opposing the legalization of controlled drugs such as cannabis.

Marijuana Policy Project (MPP) president Toi Hutchison stated that prohibition is the reason for large-scale illegal cannabis farming, not legalization. She argued that there is little to no illicit production of drugs such as alcohol and tobacco because they are legal under both state and federal law.

In addition, Hutchison noted that prohibition made illicit production more attractive because it drove up production costs and made it almost impossible to compete with illicit sellers.

As more companies such as India Globalization Capital Inc. (NYSE American: IGC) move toward medicalizing cannabis compounds, the discussion on this plant will broaden as growing numbers of people seek FDA-approved treatments made from this divisive substance.

NOTE TO INVESTORS: The latest news and updates relating to India Globalization Capital Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer




(0)
(0)




IGC Pharma Inc. (IGC) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us